Azizi H, Abbasi N, Liu L, Pastor-Bernier A, Tremblay C, Pourmajidian M, Senkevich K, Morys F, Vo A, Moqadam R, Rajimehr R, Yu E, Savadjiev P, Markello RD, Shafiei G, Khatibi N, Jahanshad N, Thompson PM, Poline JB, Gan-Or Z, Misic B, Zeighami Y and Dagher A. Brain size links neurodevelopment to neurodegeneration in Parkinson’s disease. Under review. 2026. Preprint, PubMed
Author: meron
Genome-wide association study of REM-sleep behaviour disorder identifies new risk loci
Somerville EN, Liu L, Krohn L, Asayesh F, Ahmad J, Spiegelman D, Teferra M, Tan M, Waters S, Simonet C, Pérez-Carbonell L, Schrag A, Dodet P, Arnulf I, Hu MTM, Ju YE, Montplaisir JY, Gagnon JF, Desautels A, Dauvilliers Y, Aktan-Süzgün M, Ibrahim A, Stefani A, Hogl B, Gaig C, Montini A, Maya G, Iranzo A, Serradell M, Gigli GL, Valente M, Janes F, Bernardini A, Sonka K, Kemlink D, Dusek P, Tamgüney G, Sommerauer M, FigorilliM, Puligheddu M, Mollenhauer B, Trenkwalder C, Sixel-Doring F, Plazzi G, Biscarini F, Antelmi E, Cochen De Cock V, Oertel W, Janzen A, Terzaghi M, Fiamingo G, Heidbreder A, Monaca CC, Ferini-Strambi L, Kulsarova K, Ostrozovicova M, Skorvanek M, Dijkstra F, Viaene M, Bušková J, Abril B, Orso B, Mattioli P, Arnaldi D, Boeve BF, Rouleau GA, Postuma RB, Chung J, Prilutsky D, Atterling Brolin K, Noyce AJ, Ross OA, Blauwendraat C and Gan-Or Z. Genome-wide association study of REM-sleep behaviour disorder identifies new risk loci. Under review. 2026. Preprint, Pubmed
Genomic structural equation modeling of impulsivity and risk-taking traits reveals three latent factors distinctly associated with brain structure and development
Shishikura M, Liu L, Yu E, Zhu R, Vilar-Ribó L, Cupertino RB, Palmer AA, Sanchez-Roige S, Vainik U, Morys F, Gan-Or Z, Misic B, Dagher A. Genomic structural equation modeling of impulsivity and risk-taking traits reveals three latent factors distinctly associated with brain structure and development. Under Review. 2026. Preprint, PubMed.
Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson’s disease.
Tan MMX, Iwaki H, Bandres-Ciga S, Sosero Y, Shoai M, Brockmann K, Williams NM, Alcalay RN, Maple-Grødem J, Alves G, Tysnes OB, Auinger P, Eberly S, Heutink P, Simon DK, Kieburtz K, Hardy J, Williams-Gray CH, Grosset DG, Corvol JC, Gan-Or Z, Toft M and Pihlstrøm L. Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson’s disease. Under review. 2026. Preprint, PubMed
Neuroanatomical correlates of polygenic risk for Parkinson Disease.
Abbasi N, Tremblay C, Rajimehr R, Yu E, Markello RD, Shafiei G, Khatibi N, The ENIGMA-Parkinson’s study, Jahanshad N, Thompson PM, Gan-Or Z, Misic B and Dagher A. Neuroanatomical correlates of polygenic risk for Parkinson Disease. Under review. 2026. Preprint, PubMed
Loss-of-Function Variants in CPT1C: No Support for a Causal Role in Hereditary Spastic Paraplegia
Zhu R, Liu L, Estiar MA, Asayesh F, Ahmad J, Teferra M, Yoon G, Tarnopolsky M, Boycott KM, Dupre N, Dion PA, Suchowersky O, Jordanova A, Lee YC, Stevanin G, Zuchner S, Rouleau GA, Gan-Or Z. Loss-of-Function Variants in CPT1C: No Support for a Causal Role in Hereditary Spastic Paraplegia. Mov Disord. 2025. Preprint, PubMed.
Lack of Association Between G6PD Variants and Parkinson’s Disease
Chifamba LV, Parlar SC, Liu L, Sokol LL, Yu E, Asayesh F, Ahmad J, Ruskey JA, Spiegelman D, Waters C, Monchi O, Dauvilliers Y, Dupré N, Timofeeva A, Emelyanov A, Pchelina S, Miliukhina I, Greenbaum L, Hassin-Baer S, Alcalay RN, Espay AJ, Gan-Or Z, Senkevich K. Lack of Association Between G6PD Variants and Parkinson’s Disease. HGG Adv. 2025. Preprint, PubMed.
No Evidence for Genetic Role of the Tumor Necrosis Factor Pathway in Parkinson’s Disease.
Lack of epistatic interaction of SNCA with APOE in synucleinopathies
Saini P, Yu E, Estiar MA, Krohn L, Mufti K, Rudakou U, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Arnulf I, Montplaisir JY, Gagnon JF, Desautels A, Dauvilliers Y, Gigli GL, Valente M, Janes F, Bernardini A, Šonka K, Kemlink D, Oertel WH, Kaivola K, Janzen A, Plazzi G, Antelmi E, Biscarini F, Figorilli M, Puligheddu M, Mollenhauer B, Trenkwalder C, Sixel-Döring F, Cochen De Cock V, Monaca CC, Heidbreder A, Ferini-Strambi L, Dijkstra F, Viaene M, Abril B, Boeve BF, Postuma RB, Rouleau GA, Anselmi V, Ibrahim A, Stefani A, Högl B, Hu MTM, Scholz SW, Gan-Or Z. Lack of epistatic interaction of SNCA with APOE in synucleinopathies. Brain Commun. 2025. Preprint, PubMed
GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson’s Disease Susceptibility
Parlar SC, Lee Y, Gan-Or Z. GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson’s Disease Susceptibility. Mov Disord. 2025. Preprint, PubMed.